Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. | President and Chief Executive Officer, Director | Stock Option (right to buy) | 435K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOWL | Werewolf Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | President and Chief Executive Officer, Director |
HOWL | Werewolf Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 9, 2023 | President and Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director |
HOWL | Werewolf Therapeutics, Inc. | Jan 6, 2022 | 1 | $0 | 4 | Jan 18, 2022 | President and Chief Executive Officer, Director |